Published April 25, 2000
by Icon Group International .
Written in English
|The Physical Object|
|Number of Pages||17|
Vericel Corporation is an integrated, commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Aastrom Biosciences Inc. is a North Carolina Business Corporation filed on Septem The company's filing status is listed as Current-Active and its File Number is The Registered Agent on file for this company is Ct Corporation System and is located at Fayetteville St., Box , Raleigh, NC Founded: Aastrom Biosciences, Inc. is a leader in the development of human cell therapy products intended for a broad range of medical applications based . ANN ARBOR, Mich., Aug. 13, (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announced today that it has priced a public offering of 29,, shares of its common stock, and .
Glassdoor gives you an inside look at what it's like to work at Aastrom Biosciences, including salaries, reviews, office photos, and more. This is the Aastrom Biosciences company profile. All content is posted anonymously by employees working at Aastrom Biosciences.5/5(5). Aastrom Biosciences, a longtime Ann Arbor biotech company, is moving its headquarters to the Boston area and changing its name. The publicly traded company, which has been pursuing adult stem cell. Vericel manufactures advanced cell therapies for the sports medicine and severe burn care markets. The goal of our therapies is to repair or restore a patient’s damaged tissues or organs using their own cells. Please use the links to the right to visit our product websites. MACI procedure offering a different approach to knee surgery. ANN ARBOR, Mich., Oct. 9, (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases Author: Aastrom Biosciences, Inc.
Aastrom Biosciences. 9 likes. Community. Facebook is showing information to help you better understand the purpose of a ers: SAGE Video Bringing teaching, learning and research to life. SAGE Books The ultimate social sciences digital library. SAGE Reference The complete guide for your research journey. SAGE Navigator The essential social sciences literature review tool. SAGE Business Cases Real world cases at your fingertips. CQ Press Your definitive resource for politics, policy and people. ASTM's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! : The #1 Source For Dividend Investing. Aastrom Biosciences has developed a proprietary cell-processing technology that enables the manufacture of ixmyelocel-T, a patient-specific multicellular therapy expanded from a small sample of a patient's own bone marrow. Ixmyelocel-T is produced under current good manufacturing practices (cGMP) in a fully closed, automated system that expands Cited by: